November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Highlights from the 43rd ESSO
Oct 5, 2024, 14:02

Highlights from the 43rd ESSO

The 43rd ESSO  took a place from October 2 to October 4, 2024, in Antwerp, Belgium.

The European Society of Surgical Oncology (ESSO) is a professional organization established in 1981. Its primary mission is to advance the science and practice of cancer surgery for the benefit of patients through education, research, and innovation. The society aims to unify the surgical oncology community and advocate for the importance of surgical oncology in cancer treatment.

ESSO organizes Europe’s largest annual congress in surgical oncology, bringing together over 4,000 members from various disciplines. This annual event is a significant gathering for professionals in the field of surgical oncology, focusing on innovation and education.

This year’s program focuses on Innovation and Education in Surgical Oncology. Particular emphasis is given to trending technologies in treating cancer, such as AI, fluorescence-guided surgery, and robotic surgery.

ESSO

ESSO:

“We’re excited to announce the new ESSO Board of Directors for 2024-2026!  A big welcome to our new leadership team.”

ESSO

Veronika Patsko:

“Oncology has its own superstars. Had an honor to meet the “father” of the golden standard of gastric cancer surgery – Professor Mitsuru Sasako.”

ESSO

 

 

 

Tibor Kovacs:

“As the Chair of the European Society of Surgical Oncology (ESSO) Nomination Committee it has been an honor to recommend for approval by the General Assembly the new Board of the Society for 2024-2026! Congratulations to all!”

ESSO

 

 

 

Gabrielle van Ramshorst:

“Mitsuru Sasako announced as recipient of the ESSO Gold Medal 2024 for his contributions towards gastric cancer surgery ESSO43.”

ESSO

Dona Sochorova:

“Debate on prophylactic HIPEC for T4 colorectal cancer at ESSO43 – well-pointed arguments by Wim Ceelen, Andreas Brandl: So far studies: unprecise T4 staging + MSI high pts + underpowered

Evidence is poor- need a (good) trial.”

ESSO

Nada Santrac:

European Society of Surgical Oncology (ESSO) annual congress has unofficially started for us!

Encounters with old friends and some new ones in European Society of Surgical Oncology (ESSO) Young Surgeons and Alumni Club (EYSAC) are always a great opportunity for fun, but also for a lot of quality brainstorming, since we have a lot of work to do during the congress and many engagements within the ESSO43 Scientific program that is diverse and inclusive, especially for the young ESSO members. Here, our voice can be heard!

We have started strong, and are already making plans for interesting collaborations worldwide, under the auspices of the European Society of Surgical Oncology (ESSO).

Join us from October 2-4th in Antwerp and enjoy interesting symposia, debates and meet-the-expert sessions that Scientific Committee has prepared for this year!

Some tips if you’re first time attending ESSO congress:

Make sure to also visit our ESSO booth and EYSAC booth, because we have prepared some new and interesting contents for our members.

Use the opportunity to officially join ESSO and EYSAC.

Young ESSO members are welcome to join the EYSAC Forum!

I welcome you in the name of ESSOEYSAC family․”

ESSO

Roger Olofsson Bagge:

“Nice walk-through of the IMPORT-LOW trial, important to de-escalate also radiotherapy in breast cancer, and a new standard of care! Great start of the breast session!”

ESSO

 

 

Marta Jimenez Gomez:

 

“Why Clinical trial protocols should be registered Before the start of the study? A Good question answered by Celeem Wim in the Research Methodology Session at ESSO43.”

ESSO

 

Karol Polom:

“5 European young surgeons EYSAC presidents 5 visions 1 goal to improve surgical care and training with European Society of Surgical Oncology

Karol Połom 2016-18 , Poland
Laura Lorenzon 2018-20, Italy
Andreas Brandl 2020-22, Germany
Carmela Caballero 2022-24, Belgium
Nada Santrac 2024-26, Slovenia .”

ESSO

Anna M. Czarnecka:

 

“Hot topic discussed during ESSO.
What is the role for surgeon <in modern treatment of skin cancer and melanoma>

 

ESSO on the role of surgeon in the modern world of targeted therapy, immunotherapy and cancer, vaccines.”

 

ESSO

 

Daniel Martins Jordão:

“Amazing days at ESSO 43!
Good friends and great lectures

We were pleased to show the reconstructive results from our advanced pelvic malignancy group at ULS Santa Maria

And i am honoured to have been nominated EYSAC national representative for Portugal for the 24-26 term.”

Highlights from the 43rd ESSO

Pankaj K. Garg:

“Honoured to attend ESSO43 in Antwerp and receive the Best Clinical Trial Award!  Thank you EYSAC and Anticancer Fund.

Was great to catch up with friends and colleagues!

Looking forward to ESSO44.”

Highlights from the 43rd ESSO

Andreas Brandl:

 

“Returning from an inspiring ESSO43 Congress in Antwerp!  Incredible scientific program, cutting-edge research, and great discussions on the future of Surgical Oncology. Amazing to meet and reconnect with colleagues – excited for future collaborations!”

Highlights from the 43rd ESSO

Marta Jimenez Gomez:

“Another ESSO congress has gone.. this year was amazing due to EYSAC group of colleagues that made me feel so welcome! So glad for this 3 days of great sessions and knowledge but also for meeting with old and new friends all over the globe!”

Highlights from the 43rd ESSO

More posts featuring ESSO on oncodaily.com